ERBiome℠ Test

product-ERBiome-hero

Determining the optimal endometrial environment

CooperSurgical’s ERBiome℠ test evaluates your patient’s endometrial microbiome to guide your personalized treatment strategy.

ERBiome helps you determine the:
• Relative abundance of lactobacillus
• Presence or absence of known reproductive tract pathogens

Availability

This service is available for sale in selected countries around the world.

Importance of lactobacillus

A dominance of lactobacillus and absence of endometritis provides a favorable environment for implantation1,2

≥90% lactobacillus 61% implantation rate

<90% lactobacillus 23% implantation rate

Easy result interpretation

A Lacto-dominant or Non-Lacto-dominant result is given along with detected reproductive tract pathogens, known to impact implantation outcomes.

Reproductive tract pathogens detected by ERBiome

Atopobium vaginae
Prevotella bivia
Bacteroides fragilis
Ureaplasma urealyticum
BVAB2
Enterococcus faecalis
Gardnerella vaginalis
Escherichia coli
Megasphaera 1

Streptococcus agalactiae B
Megasphaera 2
Haemophilus ducreyi
Mobiluncus curtisii
Mycoplasma genitalium
Mobiluncus mulieris
Neisseria gonorrhoeae
Mycoplasma hominis
Treponema pallidum

Get In Touch With Us

We’d love to hear from you. How can we help?

Brochures, Catalogs & Flyers

The ERBiome test is considered a screening test and should not be solely used to diagnose or treat any condition

1. Moreno et al, Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016
2. Elnashar, A.M. Impact of endometrial microbiome on fertility. Middle East Fertil Soc J, 2021

Procedures

Procedure-embryoBiopsy-FI

Embryo Biopsy

The full solution for efficient and effective biopsy procedures

Get In Touch With Us

We’d love to hear from you. How can we help?